RNASEH1 and cancer: A pan-cancer analysis revealed that overexpression of RNASEH1 is associated with the regulation of the TME and poor prognosis, suggesting that RNASEH1 may promote BLCA immune escape by inhibiting anti-tumor immunity (48).